88 related articles for article (PubMed ID: 11530936)
1. Toward understanding the role of insulin alpha-helix II in the growth-promoting activity of insulin.
Chen H; Feng YM
Biol Chem; 2001 Jul; 382(7):1057-62. PubMed ID: 11530936
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the residue Glu9, Glu46, and Phe49 to the biological activity of insulin-like growth factor-1.
Chen H; Feng YM
IUBMB Life; 2001 Jan; 51(1):33-7. PubMed ID: 11419693
[TBL] [Abstract][Full Text] [Related]
3. Studies on insulin/IGF-1 hybrid and IGF-1 growth-promoting functional region.
Wang P; Cai RR; Feng YM; Zhang YS
IUBMB Life; 2000 Apr; 49(4):321-5. PubMed ID: 10995036
[TBL] [Abstract][Full Text] [Related]
4. How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor.
Huang K; Xu B; Hu SQ; Chu YC; Hua QX; Qu Y; Li B; Wang S; Wang RY; Nakagawa SH; Theede AM; Whittaker J; De Meyts P; Katsoyannis PG; Weiss MA
J Mol Biol; 2004 Aug; 341(2):529-50. PubMed ID: 15276842
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of insulin-like growth factor II (IGF-II) interaction with domain 11 of the human IGF-II/mannose 6-phosphate receptor: function of CD and AB loop solvent-exposed residues.
Zaccheo OJ; Prince SN; Miller DM; Williams C; Kemp CF; Brown J; Jones EY; Catto LE; Crump MP; Hassan AB
J Mol Biol; 2006 Jun; 359(2):403-21. PubMed ID: 16631789
[TBL] [Abstract][Full Text] [Related]
6. Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor I.
Schaffer ML; Deshayes K; Nakamura G; Sidhu S; Skelton NJ
Biochemistry; 2003 Aug; 42(31):9324-34. PubMed ID: 12899619
[TBL] [Abstract][Full Text] [Related]
7. Mutagenesis of the human interleukin-6 fourth predicted alpha-helix: involvement of the Arg168 in the binding site.
Fontaine V; Ooms J; Content J
Eur J Immunol; 1994 May; 24(5):1041-5. PubMed ID: 8181515
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the three conserved valine residues of insulin and a proposal of "isosteric residue".
Guo ZY; Tang YH; Zhang Z; Feng YM
IUBMB Life; 2001 Dec; 52(6):309-14. PubMed ID: 11895080
[TBL] [Abstract][Full Text] [Related]
9. In vitro evolution of amphioxus insulin-like peptide to mammalian insulin.
Guo ZY; Shen L; Gu W; Wu AZ; Ma JG; Feng YM
Biochemistry; 2002 Aug; 41(34):10603-7. PubMed ID: 12186544
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein-2: contributions of the C-terminal domain to insulin-like growth factor-1 binding.
Kibbey MM; Jameson MJ; Eaton EM; Rosenzweig SA
Mol Pharmacol; 2006 Mar; 69(3):833-45. PubMed ID: 16306230
[TBL] [Abstract][Full Text] [Related]
11. Chiral mutagenesis of insulin's hidden receptor-binding surface: structure of an allo-isoleucine(A2) analogue.
Xu B; Hua QX; Nakagawa SH; Jia W; Chu YC; Katsoyannis PG; Weiss MA
J Mol Biol; 2002 Feb; 316(3):435-41. PubMed ID: 11866509
[TBL] [Abstract][Full Text] [Related]
12. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
[TBL] [Abstract][Full Text] [Related]
13. Mutagenesis analysis of the serotonin 5-HT2C receptor and a Caenorhabditis elegans 5-HT2 homologue: conserved residues of helix 4 and helix 7 contribute to agonist-dependent activation of 5-HT2 receptors.
Xie J; Dernovici S; Ribeiro P
J Neurochem; 2005 Jan; 92(2):375-87. PubMed ID: 15663485
[TBL] [Abstract][Full Text] [Related]
14. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of insulin and insulin-like growth factor-1 hybrid receptors and decreased glycosylation of the insulin receptor alpha- and beta-subunits in scrapie-infected neuroblastoma N2a cells.
Nielsen D; Gyllberg H; Ostlund P; Bergman T; Bedecs K
Biochem J; 2004 Jun; 380(Pt 2):571-9. PubMed ID: 15025560
[TBL] [Abstract][Full Text] [Related]
16. Mapping of the insulin-like growth factor II binding site of the Type I insulin-like growth factor receptor by alanine scanning mutagenesis.
Sørensen H; Whittaker L; Hinrichsen J; Groth A; Whittaker J
FEBS Lett; 2004 May; 565(1-3):19-22. PubMed ID: 15135045
[TBL] [Abstract][Full Text] [Related]
17. Importance of the solvent-exposed residues of the insulin B chain alpha-helix for receptor binding.
Glendorf T; Sørensen AR; Nishimura E; Pettersson I; Kjeldsen T
Biochemistry; 2008 Apr; 47(16):4743-51. PubMed ID: 18376848
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a second ligand binding site of the insulin receptor.
Hao C; Whittaker L; Whittaker J
Biochem Biophys Res Commun; 2006 Aug; 347(1):334-9. PubMed ID: 16814253
[TBL] [Abstract][Full Text] [Related]
19. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor.
Ward CW; Lawrence MC
Bioessays; 2009 Apr; 31(4):422-34. PubMed ID: 19274663
[TBL] [Abstract][Full Text] [Related]
20. pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity.
Kohn WD; Micanovic R; Myers SL; Vick AM; Kahl SD; Zhang L; Strifler BA; Li S; Shang J; Beals JM; Mayer JP; DiMarchi RD
Peptides; 2007 Apr; 28(4):935-48. PubMed ID: 17328992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
